These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24107354)

  • 1. Doctors' groups are criticised for endorsing pro-industry guidelines.
    Arie S
    BMJ; 2013 Oct; 347():f6066. PubMed ID: 24107354
    [No Abstract]   [Full Text] [Related]  

  • 2. Conflicts of interest of clinicians associated with document on collaboration between doctors and drug industry still being sought.
    Griffith D
    BMJ; 2013 Feb; 346():f1188. PubMed ID: 23444436
    [No Abstract]   [Full Text] [Related]  

  • 3. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From quid pro quo to quid pro bono: reshaping the influence of industry on health care epidemiologists.
    Kirkland KB
    Clin Infect Dis; 2010 Jan; 50(1):93-7. PubMed ID: 19951230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US dietary committee criticised for ties to industry.
    Nelson R
    Lancet; 2003 Sep; 362(9386):808. PubMed ID: 13678891
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflicts of interest: honours or honoraria.
    Sivakumaran M
    Lancet; 2003 Sep; 362(9387):922. PubMed ID: 13678996
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug buddies.
    Ledford H
    Nature; 2011 Jun; 474(7352):433-4. PubMed ID: 21697923
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards greater transparency in the life sciences.
    Thompson R; Khanna D
    BMJ; 2012 May; 344():e3371. PubMed ID: 22589510
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for collaboration with industry should be transparent.
    Goldacre B; Carroll D; Hall E
    BMJ; 2013 Oct; 347():f6100. PubMed ID: 24108171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conflicts of interest and clinical drug trials -- impact of the pharmaceutical industry and the impingement on the integrity of medical science].
    Ludwig WD; Hildebrandt M; Schott G
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(3):149-54. PubMed ID: 19554889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards of ethics at the National Institutes of Health.
    Steinbrook R
    N Engl J Med; 2005 Mar; 352(13):1290-2. PubMed ID: 15800225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflexions on gifts from the pharmaceutical industry].
    Pérez-Castro Ellendt E
    Arch Esp Urol; 1998 Dec; 51(10):955-6. PubMed ID: 9951114
    [No Abstract]   [Full Text] [Related]  

  • 13. Scripts for science: a new wrinkle on academic ties with industry.
    Hauser SL; Johnston SC
    Ann Neurol; 2008 Oct; 64(4):A13-5. PubMed ID: 18991356
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry and medicine: conflicting interests and the power of money.
    Popovsky MA; Garcia N
    Transfusion; 2007 Jun; 47(6):1098-9. PubMed ID: 17524103
    [No Abstract]   [Full Text] [Related]  

  • 15. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 16. New UK guidance on industry-health professional collaboration.
    Mintzes B
    BMJ; 2012 Jun; 344():e3952. PubMed ID: 22700788
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflict of interest. Stung by controversy, biomedical groups urge consistent guidelines.
    Kaiser J
    Science; 2007 Jul; 317(5837):441. PubMed ID: 17656694
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 20. Collaboration with drug industry won't affect clinical decisions, says new guide.
    Dyer C
    BMJ; 2012 Apr; 344():e2489. PubMed ID: 22474307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.